Impact of a VI-polysaccharide conjugate vaccine in preventing Typhoid Fever in an endemic setting, Lalitpur, Nepal
<p>Globally, an estimated 11 to 21 million cases of febrile illness and 117,000 to 161,000 deaths are attributed to typhoid fever each year. Typhoid fever is prevalent mainly in low-resource settings with poor water, and inadequate sanitation and hygiene facilities, with South Asia accounting...
Yazar: | Shakya, M |
---|---|
Diğer Yazarlar: | Pollard, A |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2022
|
Konular: |
Benzer Materyaller
-
Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
Yazar:: Maile T. Phillips, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01) -
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
Yazar:: Sodiomon B. Sirima, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01) -
Costs of typhoid vaccination for international travelers from the United States
Yazar:: Heesoo Joo, ve diğerleri
Baskı/Yayın Bilgisi: (2025-03-01) -
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
Yazar:: Nginache Nampota-Nkomba, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01) -
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
Yazar:: Megan E Carey, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)